Table 1 Demographic and clinical characteristics of the study population
Characteristics | Ever with HPV CC (N = 1038) | No-HPV CC (N = 3446) | P-value |
|---|---|---|---|
Age at baselinea | 38.3 (10.0) | 41 (11.4) | < 0.0001 |
Age at HIV diagnosis a | 31.6 (8.8) | 35.3 (10.7) | < 0.0001 |
Age at first HPV-CCa | 41.8 (10.6) | – | – |
Race | |||
Black | 596 (57.4) | 2079 (60.3) | < 0.0001 |
White | 430 (41.4) | 1203 (34.9) | |
Others | 12 (1.2) | 164 (4.8) | |
Median follow-up years | 2.6 (0.9–5.3) | 4.4 (1.9–8.0) | < 0.0001 |
Gender | |||
Male | 779 (75.0) | 2650 | 0.64 |
Female | 249 (24.0) | 782 | |
Transgender | 10 (1.0) | 14 | |
HIV risk factors | |||
MSM | 646 (63.2) | 1656 | < 0.0001 |
Heterosexual | 299 (29.2) | 1384 | |
IVDU | 77 (7.5) | 300 | |
Others | 1 (0.1) | 5 | |
Mean Log VL (copies/mL) | 5.3 (5.9) | 5.2 (5.8) | 0.59 |
Nadir CD4 (cells/μL)b | 237 (72–701) | 369 (0–899) | < 0.0001 |